Resilience as a metric: Why midlife interventions matter more than ever

Resilience as a metric: Why midlife interventions matter more than ever Dr Rebecca Crews and Heather Makar from Renue By Science advocate for changing health policy to prioritize proactive resilience maintenance over reactive disease treatment, especially during midlife. They emphasize the benefits of NAD+ biology as a measurable intervention framework. Health policy is balanced at an inflection point. By 2050, the global population aged 60 and older will reach 2.1 billion, while birth rates decline across developed nations. Simultaneously, chronic diseases now affect younger cohorts at unprecedented rates. Type 2 diabetes among thirty-somethings has increased 70% between 1990 and 1998, with reason to believe that percentage is even greater today, while cognitive decline markers appear decades before clinical diagnosis.